ArticlePharmacology research & perspectives2015

TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models.

Sophie Schaller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.